Orphazyme

-$0.17 (-4.00%) As of 7:18 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Orphazyme and other ETFs, options, and stocks.

About ORPH

Orphazyme A/S is a biopharmaceutical company, which engages in the development of treatment for patients living with life-threatening and debilitating rare diseases. It provides Arimoclomol program and molecular entities program.

CEO
Christophe Bourdon
Employees
141
Headquarters
Copenhagen, Capital Region
Founded
2009

ORPH Key Statistics

Market Cap
147.38M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
2.95M
High Today
$4.19
Low Today
$4.02
Open Price
$4.15
Volume
1.24M
52 Week High
$77.77
52 Week Low
$3.78
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure